Breaking News Instant updates and real-time market news.

HLUYY

Lundbeck

$20.00 /

+ (+0.00%)

12:46
07/01/22
07/01
12:46
07/01/22
12:46

Lundbeck price target raised to DKK 46 from DKK 40 at JPMorgan

JPMorgan analyst James Gordon raised the firm's price target on Lundbeck to DKK 46 from DKK 40 and keeps an Overweight rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Pear Therapeutics price target lowered to $5 from $11 at BTIG » 08:12
08/12/22
08/12
08:12
08/12/22
08:12
PEAR

Pear Therapeutics

$2.25 /

+0.27 (+13.64%)

BTIG analyst Marie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

07:48 Today Chardan
Pear Therapeutics price target lowered to $9 from $13 at Chardan
06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
05/17/22 Chardan
Pear Therapeutics price target lowered to $13 from $16 at Chardan
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

Recommendations
Plug Power price target raised to $29 from $19 at Wells Fargo » 08:12
08/12/22
08/12
08:12
08/12/22
08:12
PLUG

Plug Power

$27.74 /

-1.04 (-3.61%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$27.74 /

-1.04 (-3.61%)

PLUG Plug Power
$27.74 /

-1.04 (-3.61%)

08/11/22 Citi
Plug Power price target raised to $36 from $20 at Citi
08/11/22 Truist
Plug Power price target raised to $32 from $21 at Truist
08/10/22 B. Riley
Plug Power price target raised to $32 from $31 at B. Riley
08/10/22 Cowen
Plug Power price target lowered to $35 from $44 at Cowen
PLUG Plug Power
$27.74 /

-1.04 (-3.61%)

PLUG Plug Power
$27.74 /

-1.04 (-3.61%)

PLUG Plug Power
$27.74 /

-1.04 (-3.61%)

Hot Stocks
Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx » 08:11
08/12/22
08/12
08:11
08/12/22
08:11
GH

Guardant Health

$53.10 /

+0.03 (+0.06%)

, AZN

AstraZeneca

$64.66 /

-1.175 (-1.78%)

Guardant Health (GH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$53.10 /

+0.03 (+0.06%)

AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

GH Guardant Health
$53.10 /

+0.03 (+0.06%)

08/03/22 Citi
Exact Sciences price target lowered to $50 from $65 at Citi
08/02/22 Piper Sandler
Guardant Health coverage news 'notable positive,' says Piper Sandler
08/01/22 OTR Global
Guardant Health view downgraded to Mixed from Positive at OTR Global
06/02/22 Piper Sandler
Guardant Health initiated with an Overweight at Piper Sandler
AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

08/05/22 Morgan Stanley
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
08/04/22 Barclays
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
08/01/22 JPMorgan
AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
08/01/22 Deutsche Bank
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
GH Guardant Health
$53.10 /

+0.03 (+0.06%)

AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

AZN AstraZeneca
$64.66 /

-1.175 (-1.78%)

Hot Stocks
Kalera announces revised date for Q2 financial results » 08:10
08/12/22
08/12
08:10
08/12/22
08:10
KAL

Kalera

$2.93 /

+0.19 (+6.93%)

Kalera Public Limited…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAL Kalera
$2.93 /

+0.19 (+6.93%)

KAL Kalera
$2.93 /

+0.19 (+6.93%)

07/07/22 Roth Capital
Kalera initiated with a Buy at Roth Capital
Hot Stocks
Rubicon sets record date for its $11 per share cash distribution » 08:09
08/12/22
08/12
08:09
08/12/22
08:09
RBCN

Rubicon

$16.10 /

+ (+0.00%)

Rubicon Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBCN Rubicon
$16.10 /

+ (+0.00%)

Recommendations
Rivian Automotive price target raised to $27 from $24 at DA Davidson » 08:09
08/12/22
08/12
08:09
08/12/22
08:09
RIVN

Rivian Automotive

$38.91 /

+1.475 (+3.94%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

07:02 Today Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
06:44 Today Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
07/13/22 Canaccord
Rivian Automotive initiated with a Buy at Canaccord
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

  • 10
    Nov
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

Hot Stocks
GrowGeneration CFO Jeff Lasher resigns, Greg Sanders succeeds » 08:08
08/12/22
08/12
08:08
08/12/22
08:08
GRWG

GrowGeneration

$5.62 /

-0.335 (-5.63%)

GrowGeneration announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$5.62 /

-0.335 (-5.63%)

GRWG GrowGeneration
$5.62 /

-0.335 (-5.63%)

08/05/22 Alliance Global Partners
GrowGeneration downgraded to Neutral from Buy at Alliance Global Partners
05/12/22 Oppenheimer
GrowGeneration price target lowered to $15 from $50 at Oppenheimer
05/11/22 Wells Fargo
GrowGeneration price target lowered to $4 from $8 at Wells Fargo
05/11/22 Alliance Global Partners
GrowGeneration price target lowered to $7 from $14 at Alliance Global
GRWG GrowGeneration
$5.62 /

-0.335 (-5.63%)

GRWG GrowGeneration
$5.62 /

-0.335 (-5.63%)

GRWG GrowGeneration
$5.62 /

-0.335 (-5.63%)

Hot Stocks
XpresSpa announces re-opening of XpresSpa location at JFK Airport » 08:08
08/12/22
08/12
08:08
08/12/22
08:08
XSPA

XpresSpa

/

+

XpresSpa Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XSPA XpresSpa
/

+

XSPA XpresSpa
/

+

05/18/22 H.C. Wainwright
XpresSpa price target lowered to $2 from $4 at H.C. Wainwright
03/16/22 H.C. Wainwright
XpresSpa 'dislocation' brings buying opportunity, says H.C. Wainwright
11/17/21 H.C. Wainwright
XpresSpa price target raised to $4 from $3.50 at H.C. Wainwright
XSPA XpresSpa
/

+

Hot Stocks
Applied Blockchain secures $115M credit facility » 08:07
08/12/22
08/12
08:07
08/12/22
08:07
APLD

Applied Blockchain

$2.15 /

+0.04 (+1.90%)

Applied Blockchain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLD Applied Blockchain
$2.15 /

+0.04 (+1.90%)

APLD Applied Blockchain
$2.15 /

+0.04 (+1.90%)

07/19/22 Lake Street
Marathon contract gives Lake Street confidence in Applied Blockchain growth
05/23/22 Craig-Hallum
Craig-Hallum bullish on Applied Blockchain, initiates with a Buy
05/23/22 Craig-Hallum
Applied Blockchain initiated with a Buy at Craig-Hallum
05/09/22 Lake Street
Applied Blockchain initiated with a Buy at Lake Street
APLD Applied Blockchain
$2.15 /

+0.04 (+1.90%)

  • 13
    Apr
APLD Applied Blockchain
$2.15 /

+0.04 (+1.90%)

Downgrade
K+S AG downgraded to Sector Perform from Outperform at Scotiabank » 08:07
08/12/22
08/12
08:07
08/12/22
08:07
KPLUY

K+S AG

$10.87 /

+0.28 (+2.64%)

, NTR

Nutrien

$90.51 /

+0.045 (+0.05%)

, CF

CF Industries

$101.91 /

+0.01 (+0.01%)

Scotiabank analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTR Nutrien
$90.51 /

+0.045 (+0.05%)

CF CF Industries
$101.91 /

+0.01 (+0.01%)

KPLUY K+S AG
$10.87 /

+0.28 (+2.64%)

07/18/22 Morgan Stanley
K+S AG price target lowered to EUR 24 from EUR 26.50 at Morgan Stanley
05/12/22 Morgan Stanley
K+S AG price target raised to EUR 26.50 from EUR 20.50 at Morgan Stanley
05/12/22 Scotiabank
K+S AG price target raised to EUR 40 from EUR 38 at Scotiabank
04/20/22 DZ Bank
K+S AG downgraded to Hold from Buy at DZ Bank
NTR Nutrien
$90.51 /

+0.045 (+0.05%)

08/10/22 Barclays
Nutrien price target lowered to $105 from $126 at Barclays
08/09/22 Scotiabank
Nutrien upgraded to Outperform from Sector Perform at Scotiabank
07/18/22 RBC Capital
ITC ruling against U.S. UAN tariffs negative for CF Industries, says RBC Capital
07/14/22 Credit Suisse
Nutrien initiated with an Underperform at Credit Suisse
CF CF Industries
$101.91 /

+0.01 (+0.01%)

08/10/22 Barclays
CF Industries upgraded to Overweight from Equal Weight at Barclays
08/03/22 Scotiabank
CF Industries upgraded to Outperform from Sector Perform at Scotiabank
08/03/22 Citi
CF Industries upgraded to Buy on tighter ag conditions at Citi
08/03/22 Citi
CF Industries upgraded to Buy from Neutral at Citi
NTR Nutrien
$90.51 /

+0.045 (+0.05%)

CF CF Industries
$101.91 /

+0.01 (+0.01%)

CF CF Industries
$101.91 /

+0.01 (+0.01%)

NTR Nutrien
$90.51 /

+0.045 (+0.05%)

CF CF Industries
$101.91 /

+0.01 (+0.01%)

NTR Nutrien
$90.51 /

+0.045 (+0.05%)

CF CF Industries
$101.91 /

+0.01 (+0.01%)

Hot Stocks
SciSparc issued Israeli patent for tech treating CNS disorders » 08:07
08/12/22
08/12
08:07
08/12/22
08:07
SPRC

SciSparc

$1.19 /

-0.025 (-2.06%)

SciSparc announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPRC SciSparc
$1.19 /

-0.025 (-2.06%)

Recommendations
AppLovin price target lowered to $70 from $80 at DA Davidson » 08:06
08/12/22
08/12
08:06
08/12/22
08:06
APP

AppLovin

$34.46 /

-6.01 (-14.85%)

, U

Unity

$54.30 /

-1.21 (-2.18%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$34.46 /

-6.01 (-14.85%)

U Unity
$54.30 /

-1.21 (-2.18%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

08/11/22 BTIG
AppLovin price target lowered to $53 from $60 at BTIG
08/11/22 Truist
AppLovin price target lowered to $65 from $77 at Truist
08/11/22 Credit Suisse
ironSource downgraded to Neutral from Outperform at Credit Suisse
08/10/22 Citi
AppLovin bid for Unity faces 'several challenges,' says Citi
U Unity
$54.30 /

-1.21 (-2.18%)

08/11/22 Credit Suisse
ironSource downgraded to Neutral from Outperform at Credit Suisse
08/10/22 Citi
AppLovin bid for Unity faces 'several challenges,' says Citi
08/10/22 Oppenheimer
Unity price target raised to $60 from $54 at Oppenheimer
08/10/22 Benchmark
Benchmark keeps Sell rating on Unity, doesn't think AppLovin acquires
APP AppLovin
$34.46 /

-6.01 (-14.85%)

U Unity
$54.30 /

-1.21 (-2.18%)

  • 03
    Dec
APP AppLovin
$34.46 /

-6.01 (-14.85%)

U Unity
$54.30 /

-1.21 (-2.18%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

U Unity
$54.30 /

-1.21 (-2.18%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

U Unity
$54.30 /

-1.21 (-2.18%)

Hot Stocks
Terns Pharmaceuticals announces $65M oversubscribed offering » 08:06
08/12/22
08/12
08:06
08/12/22
08:06
TERN

Terns Pharmaceuticals

$2.40 /

+0.14 (+6.19%)

Terns Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TERN Terns Pharmaceuticals
$2.40 /

+0.14 (+6.19%)

TERN Terns Pharmaceuticals
$2.40 /

+0.14 (+6.19%)

03/23/22 JPMorgan
Terns downgraded after 'firmly negative' data at JPMorgan
03/23/22 JPMorgan
Terns Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
09/14/21 Goldman Sachs
Terns Pharmaceuticals assumed with a Buy at Goldman Sachs
TERN Terns Pharmaceuticals
$2.40 /

+0.14 (+6.19%)

TERN Terns Pharmaceuticals
$2.40 /

+0.14 (+6.19%)

Hot Stocks
Vontier appoints Anshooman Aga as CFO » 08:05
08/12/22
08/12
08:05
08/12/22
08:05
VNT

Vontier

$24.16 /

-0.315 (-1.29%)

, HSC

Harsco

$6.56 /

+0.04 (+0.61%)

Vontier (VNT) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNT Vontier
$24.16 /

-0.315 (-1.29%)

HSC Harsco
$6.56 /

+0.04 (+0.61%)

VNT Vontier
$24.16 /

-0.315 (-1.29%)

07/08/22 Barclays
Vontier price target lowered to $33 from $39 at Barclays
04/04/22 Barclays
Vontier price target lowered to $40 from $42 at Barclays
03/23/22 Argus
Vontier price target lowered to $30 from $40 at Argus
02/18/22 Citi
Vontier price target lowered to $34 from $39 at Citi
HSC Harsco
$6.56 /

+0.04 (+0.61%)

07/20/22 DA Davidson
Harsco price target lowered to $13 from $16 at DA Davidson
07/18/22 Barrington
Harsco price target lowered to $13 from $20 at Barrington
07/12/22 BMO Capital
Harsco initiated with a Market Perform at BMO Capital
05/04/22 Barrington
Harsco price target lowered to $20 from $22 at Barrington
VNT Vontier
$24.16 /

-0.315 (-1.29%)

HSC Harsco
$6.56 /

+0.04 (+0.61%)

Earnings
Checkpoint Therapeutics reports Q2 EPS (16c), consensus (17c) » 08:05
08/12/22
08/12
08:05
08/12/22
08:05
CKPT

Checkpoint Therapeutics

$1.26 /

+0.03 (+2.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

07/14/22 B. Riley
Checkpoint Therapeutics resumed with a Buy at B. Riley
06/17/22 Lake Street
Checkpoint cosibelimab data 'competitive,' says Lake Street
06/07/22 Lake Street
Lake Street says Checkpoint warrants interest after cosibelimab 'shines' at ASCO
05/31/22 Cantor Fitzgerald
Cantor sees 'positive' data likely coming from Checkpoint Therapeutics in June
CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

Hot Stocks
Longeveron expects cash to cover requirements into 1H24 » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
LGVN

Longeveron

$5.96 /

-0.17 (-2.77%)

Cash and short-term…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

03/24/22 Maxim
Maxim starts Longeveron at Buy, sees stock as 'inexpensive later-stage play'
03/24/22 Maxim
Longeveron initiated with a Buy at Maxim
01/05/22 EF Hutton
Longeveron initiated with a Buy at EF Hutton
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

Downgrade
ResMed downgraded to Neutral at Citi on valuation » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
RMD

ResMed

$241.21 /

-2.37 (-0.97%)

Citi analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMD ResMed
$241.21 /

-2.37 (-0.97%)

RMD ResMed
$241.21 /

-2.37 (-0.97%)

06:33 Today RBC Capital
ResMed downgraded to Sector Perform at RBC Capital on valuation
06:18 Today RBC Capital
ResMed downgraded to Sector Perform from Outperform at RBC Capital
06:18 Today Citi
ResMed downgraded to Neutral from Buy at Citi
06/06/22 RBC Capital
ResMed upgraded to Outperform from Sector Perform at RBC Capital
RMD ResMed
$241.21 /

-2.37 (-0.97%)

RMD ResMed
$241.21 /

-2.37 (-0.97%)

Earnings
VYNE Therapeutics reports Q2 adjusted EPS (13c) vs (35c) last year » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
VYNE

VYNE Therapeutics

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYNE VYNE Therapeutics
/

+

VYNE VYNE Therapeutics
/

+

08/10/22 H.C. Wainwright
VYNE Therapeutics price target lowered to $1.50 from $7 at H.C. Wainwright
01/13/22 Roth Capital
Roth raises Journey Medical target to $17 after dermatology assets acquisition
12/06/21 H.C. Wainwright
VYNE Therapeutics assumed with a Buy at H.C. Wainwright
08/13/21 Northland
VYNE Therapeutics price target lowered to $6 from $12 at Northland
VYNE VYNE Therapeutics
/

+

Earnings
Longeveron reports Q2 EPS (27c), consensus (23c) » 08:03
08/12/22
08/12
08:03
08/12/22
08:03
LGVN

Longeveron

$5.96 /

-0.17 (-2.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

03/24/22 Maxim
Maxim starts Longeveron at Buy, sees stock as 'inexpensive later-stage play'
03/24/22 Maxim
Longeveron initiated with a Buy at Maxim
01/05/22 EF Hutton
Longeveron initiated with a Buy at EF Hutton
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

Recommendations
Oppenheimer says Leafly valuation 'beginning to look attractive' » 08:02
08/12/22
08/12
08:02
08/12/22
08:02
LFLY

Leafly

$2.25 /

-0.15 (-6.25%)

Oppenheimer analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

07:32 Today Cowen
Leafly price target lowered to $4 from $12 at Cowen
06:12 Today Benchmark
Leafly price target lowered to $6.50 from $12.00 at Benchmark
05/20/22 Cowen
Cowen starts Leafly with Outperform with its early mover advantage
05/20/22 Cowen
Leafly initiated with an Outperform at Cowen
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

Earnings
Crinetics reports Q2 EPS (81c), consensus (67c) » 08:02
08/12/22
08/12
08:02
08/12/22
08:02
CRNX

Crinetics

$20.58 /

-1.12 (-5.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

06/15/22 Evercore ISI
Crinetics added to Best SMID 'Core' Ideas list at Evercore ISI
11/30/21 JMP Securities
Crinetics initiated with an Outperform at JMP Securities
11/23/21 Evercore ISI
Evercore starts 'rare endo treasure trove' Crinetics at Outperform
11/23/21 Evercore ISI
Crinetics initiated with an Outperform at Evercore ISI
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

  • 13
    Apr
  • 21
    Oct
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

Earnings
PepGen reports Q2 EPS ($1.23) vs ($6.03) last year » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
PEPG

PepGen

$11.15 /

-0.27 (-2.36%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

PEPG PepGen
$11.15 /

-0.27 (-2.36%)

05/31/22 Wedbush
PepGen initiated with an Outperform at Wedbush
05/31/22 Stifel
PepGen initiated with a Buy at Stifel
05/31/22 SVB Leerink
PepGen initiated with an Outperform at SVB Leerink
05/31/22 BofA
PepGen initiated with a Buy at BofA
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

  • 06
    May
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

Recommendations
System1 price target lowered to $19 from $26 at DA Davidson » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
SST

System1

$8.69 /

+0.045 (+0.52%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

07:06 Today Benchmark
System1 price target lowered to $13 from $15 at Benchmark
07/11/22 BofA
BofA starts System1 at Buy with $12 price target
07/11/22 BofA
System1 initiated with a Buy at BofA
04/26/22 Evercore ISI
System1 initiated with an In Line at Evercore ISI
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

Earnings
BIO-key sees 2022 revenue $10M-$13M » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
BKYI

BIO-key

$2.15 /

+0.115 (+5.65%)

"BIO-key has built a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

Downgrade
Wrap Technologies downgraded to Neutral from Buy at Ladenburg » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
WRAP

Wrap Technologies

$2.07 /

+0.22 (+11.89%)

Ladenburg analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

03/11/22 Ladenburg
Wrap Technologies price target lowered to $5.25 from $6.25 at Ladenburg
01/25/22 Maxim
Wrap Technologies downgraded to Hold at Maxim on management departures
01/25/22 Maxim
Wrap Technologies downgraded to Hold from Buy at Maxim
01/03/22 Ladenburg
Ladenburg uncovers 'significant loss' of future sales for Wrap Technologies
WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.